Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAA-090 in Diabetic Neuropathy Pain
NCT00073034Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Jan 2004
- Primary completion
- Dec 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of perzinfotel in diabetic neuropathy, sponsored by Pfizer. Started Jan 2004; status: terminated.
02
Drugs
perzinfotel
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT00073034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073034.